SAM
FBT icon

SignalPoint Asset Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

SignalPoint Asset Management’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$968K Sell
5,823
-243
-4% -$41.5K 0.24% 74
2024
Q3 		$1.04M Sell
6,066
-322
-5% -$53.3K 0.24% 80
2024
Q2 		$984K Buy
6,388
+7
+0.1% +$1.05K 0.26% 81
2024
Q1 		$984K Sell
6,381
-93
-1% -$14.2K 0.27% 79
2023
Q4 		$1.02M Sell
6,474
-36
-0.6% -$5.17K 0.3% 67
2023
Q3 		$953K Sell
6,510
-41
-0.6% -$6.25K 0.3% 67
2023
Q2 		$1M Sell
6,551
-7
-0.1% -$1.09K 0.31% 68
2023
Q1 		$1.02M Sell
6,558
-45
-0.7% -$7.07K 0.32% 66
2022
Q4 		$1.02M Sell
6,603
-1,112
-14% -$164K 0.36% 67
2022
Q3 		$1.02M Sell
7,715
-63
-0.8% -$8.84K 0.39% 63
2022
Q2 		$1.05M Sell
7,778
-270
-3% -$37.2K 0.39% 63
2022
Q1 		$1.2M Sell
8,048
-143
-2% -$21.2K 0.38% 63
2021
Q4 		$1.33M Sell
8,191
-931
-10% -$151K 0.4% 62
2021
Q3 		$1.51M Sell
9,122
-150
-2% -$25.6K 0.48% 55
2021
Q2 		$1.6M Buy
9,272
+132
+1% +$21.8K 0.52% 49
2021
Q1 		$1.47M Sell
9,140
-632
-6% -$108K 0.52% 48
2020
Q4 		$1.64M Buy
9,772
+154
+2% +$25K 0.62% 37
2020
Q3 		$1.51M Sell
9,618
-869
-8% -$142K 0.63% 36
2020
Q2 		$1.76M Sell
10,487
-350
-3% -$54.9K 0.79% 28
2020
Q1 		$1.42M Sell
10,837
-873
-7% -$124K 0.75% 31
2019
Q4 		$1.74M Buy
11,710
+236
+2% +$32.4K 0.73% 30
2019
Q3 		$1.42M Buy
11,474
+370
+3% +$49.3K 0.63% 34
2019
Q2 		$1.56M Sell
11,104
-7
-0.1% -$966 0.75% 32
2019
Q1 		$1.68M Sell
11,111
-138
-1% -$19.9K 0.73% 29
2018
Q4 		$1.4M Buy
11,249
+970
+9% +$133K 0.68% 36
2018
Q3 		$1.63M Sell
10,279
-479
-4% -$72.5K 0.73% 31
2018
Q2 		$1.51M Buy
10,758
+4
+0% +$549 0.72% 33
2018
Q1 		$1.43M Sell
10,754
-74
-0.7% -$10.1K 0.69% 37
2017
Q4 		$1.35M Sell
10,828
-540
-5% -$66.7K 0.65% 34
2017
Q3 		$1.41M Buy
+11,368
New +$1.35M 0.71% 32
2017
Q2 		– Sell
-12,457
Closed -$1.31M – 139
2017
Q1 		$1.31M Buy
12,457
+699
+6% +$70K 0.37% 77
2016
Q4 		$1.07M Sell
11,758
-2,970
-20% -$278K 0.28% 82
2016
Q3 		$1.47M Sell
14,728
-1,280
-8% -$126K 0.39% 60
2016
Q2 		$1.43M Sell
16,008
-1,057
-6% -$97.1K 0.6% 35
2016
Q1 		$1.49M Buy
+17,065
New +$1.5M 0.64% 32

Other funds holding FBT

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
CAG
Csenge Advisory Group Clearwater, Florida $2.47B AUM 24.93% 1-Year Est. Return

SignalPoint Asset Management's FBT Position: Q4 2024 in Review

SignalPoint Asset Management reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 4% in Q4 2024, selling an estimated $41.5K and leaving 5,823 shares worth $968K. The position accounts for 0.24% of the portfolio, ranked #74.

SignalPoint Asset Management first reported a position in FBT in Q1 2016 and has held it in 35 quarters since. The position peaked at $1.76M in Q2 2020. 256 funds tracked by Wall St. Rank hold FBT as of Q4 2024.

  • SignalPoint Asset Management held 5,823 shares of First Trust NYSE Arca Biotechnology Index Fund worth $968K as of Q4 2024.
  • SignalPoint Asset Management sold 243 First Trust NYSE Arca Biotechnology Index Fund shares in Q4 2024, an estimated $41.5K.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.24% of SignalPoint Asset Management's portfolio in Q4 2024, its #74 holding.
  • SignalPoint Asset Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2016 and has held it in 35 quarters since.
  • SignalPoint Asset Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $1.76M in Q2 2020.
  • 256 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q4 2024.

Based on SignalPoint Asset Management's 13F filing for Q4 2024, filed 14 Jan 2025.